National Institutes of Health

President Biden has finalized deals to buy 200 million more COVID-19 vaccine doses from Pfizer and Moderna by the end of July, increasing the likelihood of delivering on his promise to have all Americans inoculated by mid-summer.

Monoclonal antibody drugs are supposed to help people with mild to moderate COVID-19 avoid the hospital, but it can be a challenge to find out where the treatment is offered. NPR has heard from people across the country who have been frustrated by this. They include Shirley Wagoner, an 80-year-old who still hits the ski slopes and helps run the family plumbing business in Spokane Valley, Wash.

The pandemic put a spotlight on health care workers and inspired many to pursue a career in medicine. The record number of applicants comes as the U.S. faces a projected shortage of physicians.

The NIH said that while the anti-malarial drug did not cause harm to patients in the study, testing showed little evidence that it would benefit patients hospitalized with COVID-19.

The video has been viewed millions of times on YouTube via links that are replaced as quickly as the video-sharing service can remove them for violating its policy against "COVID-19 misinformation."

Richard Bright says he was removed from his post because of his "insistence" that the government spend funds on "safe and scientifically vetted solutions" to address the coronavirus.

The group of experts, assembled under the agency run by Dr. Anthony Fauci, warns that using a combination of hydroxychloroquine and azithromycin could result in potential toxicities.

While there is anecdotal evidence hydroxychloroquine has helped manage some patients’ symptoms, there is no data that proves it is effective in treating or preventing COVID-19. But absent that kind of data, there has been confusion around how exactly to use the drug to treat patients sick with the virus — and whether it is effective.

An expert panel convened by the FDA says the drug Makena should be withdrawn from the market because a review of its effectiveness shows it doesn't work. But OB-GYNS who prescribe the drug disagree.

Lab chimps used in medical studies are being retired to a forested sanctuary. But scientists and workers who care for the animals say some older chimps aren't healthy enough to make the transition.